TransMedics_Logo_tagline_RGB.png
TransMedics to Report First Quarter 2020 Financial Results on May 6, 2020
April 23, 2020 16:05 ET | TransMedics
ANDOVER, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TransMedics_Logo_tagline_RGB.png
TransMedics Provides COVID-19 Pandemic Update and Announces Preliminary Financial Results for First Quarter 2020
April 13, 2020 16:05 ET | TransMedics
ANDOVER, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TransMedics_Logo_tagline_RGB.png
TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency
March 17, 2020 07:00 ET | TransMedics
ANDOVER, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TransMedics_Logo_tagline_RGB.png
TransMedics Reports Fourth Quarter and Full Year 2019 Financial Results
March 02, 2020 16:05 ET | TransMedics
ANDOVER, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TransMedics_Logo_tagline_RGB.png
TransMedics to Present at the Cowen 40th Annual Health Care Conference
February 20, 2020 16:05 ET | TransMedics
ANDOVER, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics_Logo_tagline_RGB.png
TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020
February 19, 2020 16:05 ET | TransMedics
ANDOVER, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics_Logo_tagline_RGB.png
TransMedics to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 19, 2019 08:00 ET | TransMedics
ANDOVER, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics_Logo_tagline_RGB.png
TransMedics’ Organ Care System (OCS™) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors
December 04, 2019 08:00 ET | TransMedics
ANDOVER, Mass., Dec. 04, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics_Logo_tagline_RGB.png
TransMedics Reports Third Quarter 2019 Financial Results
November 06, 2019 07:30 ET | TransMedics
ANDOVER, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics_Logo_tagline_RGB.png
TransMedics Announces Change to Time of Third Quarter 2019 Earnings Conference Call on Wednesday, November 6
October 23, 2019 16:05 ET | TransMedics
ANDOVER, Mass. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...